Appili Therapeutics

OverviewSuggest Edit

Appili Therapeutics is developing novel approaches to lead the fight against infectious disease. The Company's approach focuses on matching clearly defined medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
TypePrivate
Founded2015
HQHalifax, CA
Websiteappilitherapeutics.com

Latest Updates

Employees (est.) (Jan 2020)17(-10%)

Key People/Management at Appili Therapeutics

Kimberly Stephens

Kimberly Stephens

CPA,, CA
Kevin Sullivan

Kevin Sullivan

Chief Executive Officer
Show more

Appili Therapeutics Office Locations

Appili Therapeutics has offices in Halifax and Toronto
Halifax, CA (HQ)
1344 Summer St #21
Toronto, CA
36 King St E #534
Show all (2)

Appili Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Appili Therapeutics total Funding

$16.3 m

Appili Therapeutics latest funding size

$4.30 m

Time since last funding

2 years ago

Appili Therapeutics investors

Appili Therapeutics's latest funding round in February 2018 was reported to be $4.3 m. In total, Appili Therapeutics has raised $16.3 m
Show all financial metrics

Appili Therapeutics Online and Social Media Presence

Embed Graph

Appili Therapeutics News and Updates

Drug developer Appili Therapeutics closes over $4.3 mln in private placement

Halifax, Nova Scotia-based Appili Therapeutics Inc, a developer of anti-infective drugs, raised over $4.3 million in a private placement. The investors included Innovacorp.

Appili Therapeutics snags over $3 mln in private placement

Nova Scotia and Toronto-based Appili Therapeutics Inc, a drug developer has raised $3,062,000 in a private placement. The investors included including Innovacorp.

Appili Therapeutics Blogs

Appili Therapeutics Announces Results of 2018 Annual and Special Meeting

HALIFAX, Nova Scotia, August 16, 2018 – Appili Therapeutics Inc. (the “Company” or “Appili”) announced today the results of the Company’s annual and special meeting of shareholders (the “Meeting”), which was held on August 15, 2018.

Appili Therapeutics Completes Phase 1 Study for ATI-1501, Its Taste-Masked Oral Metronidazole Suspension, Demonstrating Significant Improvements in Taste and Palatability

HALIFAX, Nova Scotia, July 30, 2018 – Appili Therapeutics Inc. (the “Company” or “Appili”) announced today positive top-line results of a pivotal relative bioavailability study evaluating pharmacokinetics, safety, and palatability of ATI-1501 in healthy, normal adults. Data from this study will be u…

Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase

HALIFAX, Nova Scotia, June 21, 2018 – Appili Therapeutics Inc. (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase. The event takes place June 28-29, 2018 in H…

Appili Therapeutics Frequently Asked Questions

  • When was Appili Therapeutics founded?

    Appili Therapeutics was founded in 2015.

  • Who are Appili Therapeutics key executives?

    Appili Therapeutics's key executives are Kimberly Stephens and Kevin Sullivan.

  • How many employees does Appili Therapeutics have?

    Appili Therapeutics has 17 employees.

  • Who are Appili Therapeutics competitors?

    Competitors of Appili Therapeutics include Biogen, MyoKardia and Athersys.

  • Where is Appili Therapeutics headquarters?

    Appili Therapeutics headquarters is located at 1344 Summer St #21, Halifax.

  • Where are Appili Therapeutics offices?

    Appili Therapeutics has offices in Halifax and Toronto.

  • How many offices does Appili Therapeutics have?

    Appili Therapeutics has 2 offices.